Page 282 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 282

Appendix Table C1.7. Tumor characteristics—stage
                                        Author               Database      Stage groups            1980-84     1985-      1990-94       1995-99      2000-04     2005-     Statistical       Notes
                                        Year                                                                   89                                                10        analysis
                                        PMID
                                                16
                                        Mebane               SEER          Localized disease       64.4%       59.2%                                                       NR                Data presented
                                        1990                               Regional disease        11.3%       11.9%                                                                         only for Black
                                        2258952                            Distant disease         18.7%       18.9%                                                                         and White
                                                                           [White patients]        (1980)      (1985)                                                                        individuals.
                                                             SEER          Localized disease       59.2%       52.2%                                                       NR                Data presented
                                                                           Regional disease        9.4%        12.0%                                                                         only for Black
                                                                           Distant disease         29.2%       26%                                                                           and White
                                                                           [Black patients]        (1980)      (1985)                                                                        individuals.

                                               23
                                        Dennis               SEER          Positive nodes                      4%         2.6%          1.3%                               NR
                                        2000                               Not examined                        80%        (1992)        NR
                                        10679753                           Lymph node status                   (1988)     75%           (1996)
                                                                           at diagnosis                                   (1994)
                                              31
                                        Clegg                SEER          The study provided                                                                              P<0.001           The cross-table
                                        2002                               a cross-table of the                                                                            (chi-square       suggests that the
                                        12230422                           proportion of                                                                                   test for stage x   proportion of
                                                                           patients with                                                                                   race x time       patients with
                                                                           localized/regional,                                                                             period)           distant disease
                                                                           distant or unknown                                                                                                decreased and
                                                                           cancer stage, by                                                                                                  the proportion of
                                                                           race and period of                                                                                                patients with
                                                                           study (1975-87 and                                                                                                localized/regional
                                                                           1988-97)                                                                                                          disease
                                                                                                                                                                                             increased over
                                                                                                                                                                                             time, across all
                                                                                                                                                                                             racial/ethnic
                                                                                                                                                                                             groups studied.
                                            37
                                        Jani                 SEER          AJCC stage                                                                                                        Excluded AJCC
                                        2007                               0/I                                 53%        41%           53%          65%                   P=0.025           stage IV.
                                        17505529                           II                                  20%        25%           21%          22%                   (chi-square
                                                                           III                                 26%        33%           25%          13%                   test)
                                                                                                               (1984-     (1989-93)     (1994-98)    (1999-                RR=0.86 (CI
                                                                                                               88)                                   2003)                 0.70, 0.92)














                                                                                                                        C-59
   277   278   279   280   281   282   283   284   285   286   287